Tag: CBHT

Use of compounded bioidentical hormone therapy in menopausal women: an opinion statement of the Women’s Health Practice and Research Network of the American College of Clinical Pharmacy

This article examines the use of compounded bioidentical hormone therapy (cBHT) for menopausal symptom management, raising concerns about its safety and efficacy compared to manufactured hormone therapy. The study highlights the lack of strong clinical data supporting the claimed advantages of cBHT and addresses misconceptions regarding the natural versus synthetic

Read More »

Custom-compounded bioidentical hormone therapy: why so popular despite potential harm? The case against routine use

This review critically examines the growing popularity of custom-compounded bioidentical hormone therapy (CBHT) and highlights significant safety concerns, including severe adverse events from compounding errors, such as deaths from contaminated products and cases of end-stage renal failure. Oral estrogens, particularly in excessive doses, are linked to an increased risk of

Read More »